Tumor immune niche cellular characterization

Tumor size will be measured daily over a tendays period after which tumors will be harvested and analyzed by multiplex immunohistochemistry coupled to highdimensional flow cytometry to define the 3D spatial distribution of fibroblastic stromal and immune cells and the extracellular matrix and to quantify their number variation and phenotype over time in the tumor microenvironment and draining lymph nodes